Skip to content
 

Latest Updates on Coronavirus: Older Americans Urged to Continue ‘Distancing’

High-risk individuals should practice precautions as COVID-19 circulates

Latest updates

En español

  • New York City Mayor Bill de Blasio announced on Wednesday that the city will set up checkpoints at key entry points to remind travelers of New York’s mandatory quarantine advisory issued for travelers coming from more than 30 U.S. states. The checkpoints will educate travelers on the required 14-day quarantine and remind them that failure to adhere to the rules is a violation of state law and may result in a fine. “If we’re going to hold at this level of health and safety in this city and get better, we have to deal with the fact that the quarantine must be applied consistently to anyone who has traveled,” de Blasio said in a news conference. 

  • The National Institutes of Health (NIH) is recruiting patients for two clinical trials testing monoclonal antibodies as a treatment for COVID-19 in patients who have a mild-to-moderate case of the illness, but do not require hospitalization, and in patients who are hospitalized with the virus, but not critically ill. Antibodies are infection-fighting proteins produced by immune cells. “Using an antibody generated by the immune system of a recovered COVID-19 patient gives us a jump start on finding a safe and effective therapeutic,” Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) said in a statement. “Investigating a variety of different therapeutics, including monoclonal antibodies, will help ensure that we advance towards an effective treatment for people suffering from COVID-19 disease as quickly as possible.”

  • The NIH is investing $248.7 million in new coronavirus testing technologies to help increase supply and access to lab-based and point-of-care tests by as early as September 2020. The agency has awarded contracts to seven different companies to develop the tests. “These technologies will help deliver faster results from labs and more and more test results within minutes at the point of care, which is especially important for settings like schools and nursing homes,” Health and Human Services (HHS) Secretary Alex Azar said in a statement.

  • The U.S. government has entered a $2.1 billion deal with drugmakers Sanofi and GlaxoSmithKline for a supply of 100 million doses of its experimental coronavirus vaccine so that if it proves safe and effective in clinical trials, it can be distributed to the public. The government’s Operation Warp Speed project has so far invested billions in this accelerated approach; it aims to deliver 300 million doses of a coronavirus vaccine by January 2021.

  • The Centers for Disease Control and Prevention (CDC) has updated its list of underlying health conditions that can increase the risk of severe illness from a coronavirus infection. There is strong evidence that serious heart conditions such as heart failure, coronary artery disease, or cardiomyopathies; cancer; chronic kidney disease; COPD; obesity; sickle cell disease; solid organ transplantation; and type 2 diabetes put people at risk for complications from COVID-19, the agency says. Meanwhile, there is mixed evidence that asthma, cerebrovascular disease, hypertension, pregnancy, smoking and the use of corticosteroids or other immunosuppressive medications increase risk for severe illness. 

  • New data from the Centers for Medicare & Medicaid Services (CMS) highlight the disproportionate impact the coronavirus is having on Black, Hispanic and American Indian/Alaskan Native Medicare beneficiaries, who are hospitalized at higher rates and experience higher rates of infection than white beneficiaries. The trend mirrors what's happening nationwide: Minorities are disproportionately affected by the coronavirus and the illness it causes.  AARP sent a letter to the U.S. Senate’s Special Committee on Aging on July 29, calling on lawmakers to take “immediate and meaningful action” to address the nation’s health disparities. 

  • Phase 3 clinical trials for vaccine candidates from drugmakers Moderna and Pfizer have begun. This phase will test the vaccine’s effectiveness in approximately 30,000 adult participants. Researchers from various projects are reporting promising results out of early-stage trials. The Moderna vaccine produced an immune response in all 45 participants, ages 18 to 55 years old. Two studies published July 20 in The Lancet show a vaccine candidate out of Oxford University and another from the Chinese company CanSino Biologics proved safe and produced an immune response in participants. 

  • A new report from the CDC found that recovery from COVID-19 can take a long time, even in young and otherwise healthy adults. A multistate telephone survey of symptomatic adults who had tested positive for a coronavirus infection but were not hospitalized for their illness found that 35 percent had not returned to their usual state of health two-to-three weeks after testing. Among persons aged 18 to 34 with no chronic medical conditions, nearly 1 in 5 had not returned to their usual state of health 14 to 21 days after testing positive. 

  • The U.S. has passed 4.8 million confirmed cases of COVID-19. Meanwhile, a study from the CDC finds the actual number of coronavirus cases could be anywhere from 6 to 24 times higher than the official number. Even still, a large number of Americans remain susceptible to a coronavirus infection, meaning the country is still far from achieving widespread immunity.

  • report from the CDC shows that Hispanic and nonwhite Americans under the age of 65 died in greater numbers and at disproportionate rates from COVID-19 between February and April, compared to their white counterparts. More than one-third of Hispanic decedents (34.9 percent) and nearly one-third of nonwhite decedents (29.5 percent) were under 65; only 13.2 percent of white decedents were under 65, the study shows. Researchers point to jobs or “essential activities that preclude physical distancing” as one possible explanation for the disparity and call for more studies “to understand the reasons for these differences.”

  • A new model from the University of Washington’s Institute for Health Metrics and Evaluation predicts the U.S. will see more than 200,000 deaths from the coronavirus by Nov. 1. Those numbers drop to 162,808 if at least 95 percent of people wear masks in public, the researchers write. So far more than 132,000 Americans have died from the virus; the U.S. has recorded more than 3 million cases of COVID-19 and several states are experiencing a surge in numbers.

What You Should Know About the Coronavirus



What can older adults do to reduce their risk of illness? 

Older adults and people with chronic underlying health conditions are more likely than younger, healthier people to experience serious illness from COVID-19, the disease caused by the coronavirus. Severe illness means that the person with COVID-19 may require hospitalization, intensive care, or help breathing to overcome the illness. There is no specific age at which risk increases. Rather, the Centers for Disease Control and Prevention (CDC) says “risk increases steadily as you age” with the greatest risk for severe illness being among those age 85 and older. Eight out of 10 COVID-19 deaths reported in the U.S. have been in adults 65 and older.

Part of the reason risk increases with age is because people are more likely to have other health issues later in life, and underlying health conditions are a huge driver of complications that arise from COVID-19. A June report from the CDC found that hospitalizations for people with COVID-19 were six times as high for patients with chronic health conditions, compared to otherwise healthy individuals; deaths among this population were 12 times as high.

There is the most evidence that the following conditions increase a person’s risk for severe illness from COVID-19:

  • Serious heart conditions, such as heart failure, coronary artery disease, or cardiomyopathies
  • Cancer
  • Chronic kidney disease 
  • COPD (chronic obstructive pulmonary disease)
  • Obesity (BMI of 30 or greater) 
  • Sickle cell disease
  • Solid organ transplantation 
  • Type 2 diabetes

There is mixed evidence that the following conditions increase a person’s risk for severe illness from COVID-19:

  • Asthma (moderate to severe)
  • Cerebrovascular disease
  • Hypertension
  • Pregnancy
  • Smoking
  • Use of corticosteroids or other immunosuppressive medications

There is limited evidence that the following conditions increase a person’s risk for severe illness from COVID-19:

  • Bone marrow transplantation
  • HIV
  • Immune deficiencies
  • Inherited metabolic disorders
  • Liver disease
  • Neurologic conditions 
  • Other chronic lung diseases
  • Pediatrics 
  • Thalassemia
  • Type 1 diabetes 

The CDC has issued specific guidance for older adults and people at high risk for serious outcomes. Here’s what the agency recommends:

Avoid close contact with others

The best way to dodge a coronavirus infection is to avoid being exposed to the virus. Older adults and people with underlying health conditions are encouraged to limit interactions with people outside their household as much as possible and to take preventive measures when interactions do take place. Wash your hands often with soap and water and use an alcohol-based hand sanitizer (at least 60 percent alcohol) when soap and water are not an option. Keep a distance of at least 6 feet from others when in public; cover your coughs and sneezes; and disinfect high-touch surfaces often.

The CDC also recommends wearing a cloth face covering in public to help slow the spread of the virus. Widespread use of face coverings can help to slow or stop the transmission of the virus in communities.

It’s a good idea to draft a plan in case you do become sick, experts say. Identify a designated sickroom in your home that can be used to separate sick household members from healthy ones. And identify aid organizations in your community that you can contact for help should you need it.

Stock up on supplies 

Older Americans and adults who routinely take medications should make sure they have at least a 30-day supply of prescription medicines on hand to cut down on the number of trips you need to make out in public, especially if cases of COVID-19 are spiking in your area. It’s also important to stock up on over-the-counter medications to treat fever, cough and other symptoms, as well as tissues and common medical supplies.

Major health insurers have pledged to relax prescription refill limits on “maintenance medications” in the wake of the coronavirus outbreak. Prescription refill limits are also being waived for many Medicare Advantage and Part D beneficiaries. 

If you run into difficulty stocking up on your prescriptions at the pharmacy, consider refilling your medications with a mail-order service, the CDC says. You can also ask your physician to switch your prescription from a 30-day supply to a 90-day supply to make sure you have enough medication to get through a longer period of time.

If you need to run out for necessities, the CDC has guidance on how to do so safely. On the list:

  • Stay at least 6 feet away from others while shopping and while in line.
  • Cover your nose and mouth with a cloth face covering. 
  • Consider running your errands first thing in the morning or at the end of the day when fewer people are likely to be shopping. Some stores have special shopping hours for high-risk individuals. 
  • Disinfect your shopping cart or basket with disinfectant wipes.
  • Use hand sanitizer right away if you handle money, a card or a keypad.
  • Wash your hands when you get home.
  • When getting gasoline, use disinfectant wipes on handles and buttons before you touch them; use hand sanitizer immediately after.

dynamic a logo mark for a a r p

Save 25% when you join AARP and enroll in Automatic Renewal for first year. Get instant access to discounts, programs, services, and the information you need to benefit every area of your life.


What about travel? 

The government advises against all nonessential international travel, including cruise ship travel, during the pandemic. As far as domestic travel is concerned, the CDC encourages travelers to study the current situation ahead of their trip to “learn if coronavirus is spreading in your local area or in any of the places you are going.” It’s important to reiterate that “staying home is the best way to protect yourself and others from getting sick,” the CDC states.

For older adults and others at high risk for severe illness from a coronavirus infection, traveling can be dangerous, especially if you are in close contact with others. “People at higher risk for severe illness need to take extra precautions,” the CDC says. 

There are a number of questions you should ask if you are thinking about traveling; if you decide to go forward with travel plans, the CDC has steps you can take to reduce your chances of getting sick:

  • Avoid contact with others and keep a distance of at least 6 feet from people.
  • Avoid touching your eyes, nose or mouth with unwashed hands.
  • Wash your hands often with soap and water for at least 20 seconds or use an alcohol-based hand sanitizer that contains at least 60 percent alcohol.
  • Wear a cloth face covering in public settings.
  • Pick up food at drive-throughs, curbside restaurant service or stores.

The CDC also recommends making sure that you are up to date with your routine vaccinations before you travel, including the measles-mumps-rubella (MMR) vaccine and the seasonal flu vaccine. And do not travel if you are sick or if you have been around someone with COVID-19 in the past 14 days.

The CDC, U.S. State Department and World Health Organization (WHO) websites have up-to-date travel information.

How is the coronavirus spreading?

The virus is thought to spread mainly between people in close contact with one another by respiratory droplets when an infected person coughs, sneezes or talks, according to the CDC. Those droplets can land in the mouths or noses of nearby people or be inhaled into the lungs. And emerging research shows aerosol transmission (tiny exhaled particles that can linger in indoor air) may play an important role in the spread of the virus, which reinforces the importance of mask wearing, experts say.

According to the CDC,  “the virus may be spread in other ways,” including by touching a contaminated surface or object and then touching your mouth, nose or eyes. However, this is not thought to be the main way the virus spreads, the agency maintains.

More and more studies show that COVID-19 can be spread by people before they start showing symptoms of COIVID-19 (presymptomatic) or even if they never develop symptoms (asymptomatic). Regardless, the CDC says the coronavirus is spreading “very easily and sustainably between people,” and “the more closely a person interacts with others and the longer that interaction, the higher the risk of COVID-19 spread.”

What are the symptoms?

People with COVID-19 have reported a wide range of symptoms that typically appear two to 14 days after exposure to the virus. Here is the latest list of symptoms, according to the CDC:

  • Fever or chills
  • Cough
  • Shortness of breath or difficulty breathing
  • Fatigue
  • Muscle or body aches
  • Headache
  • New loss of taste or smell
  • Sore throat
  • Congestion or runny nose
  • Nausea or vomiting
  • Diarrhea

The CDC acknowledges this list is not exhaustive; skin rashes or lesions may also be a sign of the virus.

Health experts are asking anyone who experiences symptoms to call their health care provider or local health department for advice before seeking care to avoid spreading germs to others. Those who are feeling sick and are unsure of their symptoms can also check the CDC’s interactive guide for advice on appropriate medical care.  

However, if you develop emergency warning signs — pain or pressure in the chest, new disorientation or confusion, a blue tint in your face or lips, difficulty breathing, or an inability to wake or stay awake — get medical attention immediately, health officials warn. 

The CDC also has tips for what to do if you are diagnosed with COVID-19.

What do we know about minority populations? 

Communities of color are disproportionately being affected by the virus and the illness it causes.

Black Americans and American Indians/Alaska Natives, for example, are five times as likely to be hospitalized for COVID-19 as their white counterparts, and Hispanics are four times as likely to wind up in the hospital for coronavirus infections as non-Hispanic whites, according to the CDC.

What’s more, these populations are also shouldering a disproportionate number of deaths from the coronavirus. Blacks account for nearly 23 percent of COVID-19 deaths in the U.S. to date, even though Black Americans make up about 13 percent of the country's population, according to the latest data from the CDC. More Hispanic Americans are dying at younger ages from COVID-19 than their white counterparts , federal data show. And death rates have been especially high in the Navajo Nation, which has land in Arizona, New Mexico and Utah.

Experts point to several factors to explain these troubling trends. Minority populations are more likely to have jobs that put them at risk for exposure to the virus and chronic conditions that increase the likelihood of COVID-19 complications. They also have more barriers when it comes to accessing health care and testing.

How is it treated?

The Food and Drug Administration (FDA) on May 1 issued an emergency use authorization (EUA) for Gilead Sciences’ antiviral drug remdesivir as a treatment option for people who are hospitalized with COVID-19.

The news came shortly after the NIH announced preliminary results from an international clinical trial testing remdesivir as a potential treatment for COVID-19. Researchers found that patients with severe illness who received the drug recovered faster than those who received a placebo. “Results also suggested a survival benefit,” the NIH said in a news release. The mortality rate for the group that received remdesivir was lower than for the placebo group.

The EUA — which is not the same as official FDA approval — “allows for remdesivir to be distributed in the U.S. and administered intravenously by health care providers” to treat patients who have low blood oxygen levels or who need breathing support by way of a mechanical ventilator.

Preliminary results from a study led by the University of Oxford also found the steroid drug dexamethasone reduced deaths by up to a third in severely ill patients hospitalized with COVID-19. The federal government has distributed both remdesivir and dexamethasone to states across the country and continues to invest in research into COVID-19 therapeutics.

What are prospects for a vaccine?

Several clinical trials testing the safety and effectiveness of potential vaccine candidates are underway, including one from drugmaker Moderna, which in an early trail study was found to produce an immune response in all 45 trial participants, aged 18 to 55. Phase three of its clinical trial has begun; so has a Phase three trial from Pfizer.

So when will a vaccine be available? Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) and a key member of the White House coronavirus task force, said in a June 23 hearing before the House Energy and Commerce Committee that he is “cautiously optimistic” the U.S. will have a vaccine for the coronavirus by the end of 2020 or early in 2021. He confirmed that several vaccine candidates are moving through clinical trial phases and that the federal government is taking financial risks “so that when — and I believe it will be when, not if — we get favorable candidates with good results, we will be able to make them available to the American public.” The federal government’s Operation Warp Speed project has so far invested billions in this accelerated approach.

The FDA has released a set of guidelines for drugmakers, detailing requirements for vaccine approval. Coronavirus vaccine candidates need to be at least 50 percent effective compared to a placebo in clinical trials, the agency says. And safety considerations “should be no different than for other preventive vaccines for infectious diseases.” More than 100 research teams around the world are working on vaccine development, according to the Milken Institute’s COVID-19 Treatment and Vaccine Tracker.

Will a flu shot provide protection?

There is no evidence that the flu shot or the pneumococcal vaccination will provide any protection from the coronavirus, according to CDC official Nancy Messonnier. Both, however, will increase your chances of staying healthy and staying out of the hospital during the pandemic.   

And it’s important to keep in mind that, like COVID-19, the flu can be deadly. The CDC estimates that the flu was responsible for 34,200 deaths in the 2018-19 season.

How can I take care of a sick friend?

Health officials stress that it’s important to take care of sick friends and neighbors in the community — and there’s a way to do so safely. If you are taking food to a neighbor, consider leaving it at the door. Since COVID-19 is most likely passed by respiratory droplets, this will eliminate the chance of the virus spreading.

If you are caring for someone who has COVID-19, keep a safe distance. Wash your hands often, wipe down high-touch surfaces and remind the person who is sick to wear a face mask. You should wear a face mask too. Offer to help with groceries and errands, if possible. 

Finally: Watch for warning signs of serious illness. Call the doctor if the person’s condition worsens, and seek immediate medical attention if they have difficulty breathing, pain or pressure in the chest, new confusion, an inability to wake or stay awake, or blueish lips or face. 

“I think it is great we step up to help each other, and there are some commonsense precautions to protect you," the CDC’s Messonnier said.

What if a loved one is in a nursing home?

Adults living in nursing homes and long-term care facilities are at high risk for severe sickness if infected with the coronavirus, which is why facilities across the country have banned visitation (with special consideration given to end-of-life cases).  

If you have a loved one in a nursing home or long-term care facility, visit with them virtually: Stay in touch through videoconferencing, emails and phone calls. Send pictures or letters or drop off a care package. (Not all facilities may allow this, so check first.)

Also: Identify a point of contact on staff for when you have questions and concerns. Facilities are required by the federal government to alert residents, their families and the CDC within 12 hours if a case of COVID-19 is confirmed. 

AARP has a list of six key questions to ask about circumstances at your loved one’s nursing home and questions for assisted living facilities — plus extensive coverage on the crisis in nursing homes. You can also track coronavirus cases and deaths in specific nursing homes on a new website that the federal government unveiled on June 4. AARP is also keeping track of this data. 

When will long-term care facilities ease up on their visitation policies? It could be a while. The Centers for Medicare & Medicaid Services (CMS) on May 18 said nursing homes should be “among the last to reopen” and announced recommendations to state and local governments for the reopening process. On the list: Facilities need to have routine testing and adequate supplies of personal protective equipment (PPE) and cleaning and disinfection materials. Nearby hospitals also need to have enough beds to take care of any residents who need to be transferred there. AARP has an FAQ resource for family and friends of nursing home residents who are eager to resume visits.

What is the advice on face masks?

The CDC is encouraging all Americans — even people who feel healthy — to wear cloth face masks or homemade face coverings in public when 6-feet social distancing is difficult to maintain in an effort to help slow the spread of the coronavirus. 

The masks the CDC is recommending can be purchased online or made at home. Health officials stress N95 respirator masks should be reserved for frontline health care workers.

AARP has a tutorial on how to make a face mask at home.

What, exactly, is the coronavirus?

Coronaviruses, named for their crownlike shape, are a large family of viruses that are common in many species of animals. Several coronaviruses can infect people, according to the CDC. These strains mostly cause cold-like symptoms but can sometimes progress to more complicated lower respiratory tract illnesses, such as pneumonia or bronchitis.

On rare occasion, animal coronaviruses can evolve and spread among humans, as seen with MERS and SARS. The virus at the center of the latest outbreak is being referred to as a novel (new) coronavirus, since it’s something that health officials have not seen before.

This story will be updated periodically with new developments in the global outbreak. Check back regularly.

Join the Discussion

0 | Add Yours

Please leave your comment below.

You must be logged in to leave a comment.

GO TO THIS ARTICLE